Xianlin Xu
- Topics
- Renal cell carcinoma treatment (6 papers)Cancer-related molecular mechanisms research (6 papers)RNA modifications and cancer (6 papers)
- Partner nations
- ChinaSwedenUnited States
In The Last Decade
Xianlin Xu
39 papers receiving 966 citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Molecular Biology 388
- Cancer Research 310
- Pulmonary and Respiratory Medicine 225
- Oncology 217
- Surgery 147
Countries citing papers authored by Xianlin Xu
This map shows the geographic impact of Xianlin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianlin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianlin Xu more than expected).
Fields of papers citing papers by Xianlin Xu
This network shows the impact of papers produced by Xianlin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianlin Xu. The network helps show where Xianlin Xu may publish in the future.
Co-authorship network of co-authors of Xianlin Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Xianlin Xu. A scholar is included among the top collaborators of Xianlin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianlin Xu. Xianlin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Risk factors for kidney stone disease recurrence: a comprehensive meta-analysisbreakdown → | 92 |
| 2 | 7 | |
| 3 | 41 | |
| 4 | 3 | |
| 5 | 24 | |
| 6 | 21 | |
| 7 | 41 | |
| 8 | 5 | |
| 9 | 43 | |
| 10 | 26 | |
| 11 | 26 | |
| 12 | Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma. | 47 |
| 13 | 21 | |
| 14 | [Expression of serum FSTL-1 in bone metastasis of prostate cancer and its clinical implication]. | 3 |
| 15 | 18 | |
| 16 | 21 | |
| 17 | 39 | |
| 18 | 84 | |
| 19 | 41 | |
| 20 | 3 |
About Xianlin Xu
Xianlin Xu is a scholar working on Transplantation, Cancer Research and Nephrology, having authored 39 papers that have together received 978 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (6 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (310 citations), Transplantation (38 citations) and Nephrology (86 citations). Xianlin Xu has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Min Fan, Xiaozhou He, Xiaozhou He, Dongming Chen, Renfang Xu, Qianfeng Zhuang, Xiaozhou He, Cui Li, Qianqian Shi and Kun Wang. Their work appears in journals such as The Journal of Urology, Journal of Cellular Physiology and BMC Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.